Before Congress adjourned for the holidays, the House of Representatives was able to advance legislation that reflected some Endocrine Society priorities related to EDCs. On December 3, Rep. Frank Pallone (D-NJ) introduced the Cosmetic Safety Enhancement Act (HR 5279), which would give the U.S. Food and Drug Administration (FDA) additional authority to regulate harmful chemicals...
After months of bargaining and numerous stalemates, the House of Representatives and Senate reached agreement on Fiscal Year 2020 appropriations just before funding expired on December 20. The deal also provided a “Christmas Tree” legislative vehicle for various policy measures. The spending deal was divided into two packages of individual bills covering funding for every...
Endocrine Society Focuses on Transgender Care, Drug Pricing, EDCs and more at AMA HOD
The Endocrine Society sent a delegation, including members Amanda Bell and Shivani Agarwal, to participate in the American Medical Association (AMA) House of Delegates (HOD) in November to establish policy positions on topics of importance to endocrinologists and the patients they treat. We attend the AMA meetings to further our policy agenda by garnering the support of...
While the House of Representatives has passed 10 of the 12 annual spending bills that fund the government, the Senate has passed only four, and the two chambers have not resolved their differences on any of them. House Majority Leader Steny Hoyer (D-MD) has said that the chamber will pass a second stopgap spending bill,...
Endocrine Society Scientific Leaders Share Research Priorities with NIH
During November, the Endocrine Society conducted meetings with leadership at the National Institutes of Health to discuss research goals and other opportunities to partner with the institutes to advance the field. Anne Cappola, MD, ScM, and Holly Brown-Borg, PhD, met with Richard Hodes, MD, director of the National Institute on Aging (NIA); and Jennifer Richer,...
Endocrine Society Educates Congress About the Science of PFAS Exposure
On Wednesday, November 6, the Endocrine Society hosted a congressional briefing to share the latest science with policy makers on how research conducted and funded by the National Institute of Environmental Health Sciences (NIEHS) is helping us understand and address the health effects of exposure to per- and polyfluoroalkyl substances, also known as PFAS. The...
Government Funded Until November 21; Action Needed to Finalize NIH Increase
Before departing for a two-week recess in late September, Congress passed a short-term continuing resolution (CR), H.R. 4378, to keep the government open through November 21, 2019. The CR was needed because the House of Representatives and Senate had not finalized a Fiscal Year 2020 appropriations bill before October 1, the start of the fiscal...
There is no shortage of interesting things going on in Washington, D.C., these days, from impeachment inquiries to funding the government to deciding on a Democratic nominee for the 2020 election. On September 28, our clinical leaders came to Washington to use their voice to advocate for a range of issues, including the renewal of...Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
